"CENTENNIAL, Colo., Dec. 7, 2010 /PRNewswire/ -- LABS Inc., the premier transplant reference and consultative laboratory in the country, today announced that Kevin M. Smith, Chief Operating Officer of the Colorado Institute for Drug, Device and Diagnostic Development (CID4), has joined the company's Board of Directors. Smith brings a wealth of experience running businesses in the biosciences industries.
In addition to his current role as COO of CID4, Smith was a member of the group that developed the original business plan and state grant proposal for the organization. He also sits on the boards of Sophono, Inc.; PeptiVir, Inc., and participates on the Centura Audit and Corporate Responsibility Management Committee."
Link to the PR Newswire release
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment